Alida Bio

Alida Bio

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.alidabio.com

Last Round

Grant

Jun 12, 2024

Total Funding Raised

$13.96M

Company Overview

Alida Bio is a biotechnology company focused on developing innovative RNA biology technologies to enhance human health by facilitating the discovery of new drugs and therapeutics for effective medical treatments and diagnostic assays.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

epitranscriptomicsRNA modificationsRNA library prep kitmultiplexed assaylow-input RNA analysisbioinformatics softwareNGS library prepproximity barcodinglife science research toolsnon-antibody protein bindersNABsbiomarker discoverydrug discovery toolsgene regulationresearch use onlyRUO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alida Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Alida Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJun 12, 2024
Series AJun 12, 2024
GrantMay 1, 2023
GrantAug 17, 2021

Key People

Founding team and executive leadership

Gudrun Stengel

CEO Co-Founder

Founding Team

Alida Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Partnered with Storm Therapeutics to develop cancer therapies.

  • Dec 4, 2025

    Launched EpiPlex Duo-Mod Service for concurrent m6A and inosine mapping.

Alida Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Alida Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alida Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range18
Year Founded2020
Last FundingJun 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.